Business Description
LigaChem Biosciences is a South Korean drug development company focused on creating new treatments for diseases that currently lack effective solutions. Founded in 2006 and based in Daejeon, the company works across several medical fields, including cancer treatment, infection control, and immune system disorders, with particular expertise in a drug delivery technology known as antibody-drug conjugates. LigaChem has partnered with Amgen to develop and bring these therapies to market, and it also sells medical devices and supplies alongside its core research activities.
